Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...

RSV vaccination for adults aged 60+ could prevent significant LRTD cases, hospitalizations, and deaths over five years. A ...

ACA marketplace premiums are projected to rise by 26% in 2026, with potential further increases if premium tax credits expire ...

Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, ...

Phung explained that prior response often guides selection: Patients who respond poorly to frontline therapy may move to CAR ...

Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...

Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...

Brigid Groves, PharmD, MS, discusses the importance of using trustworthy sources so that pharmacists can support communities ...

Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity ...

Panelists discussed these questions during a recent Institute for Value-Based Medicine® event held in Nashville, Tennessee, ...

It is necessary to balance rigorous clinical trials with real-world evidence (RWE) to show how data from everyday practice ...

Innovative cancer therapies are transforming treatment landscapes, yet access challenges persist. Experts discuss strategies ...